Established under Law No. 13,098/2015, Brazil’s National Health Surveillance Day is observed on August 5th, a date honoring the birth of physician and public health pioneer Oswaldo Cruz. Beyond its commemorative character, the date reinforces the scope of a regulatory function that, while often associated with punitive enforcement, operates continuously and largely unnoticed across nearly every stage of the population’s daily life.

One continuous protection network in six fronts

Health surveillance follows the Brazilian consumer even when unnoticed:

▪ food safety is ensured, since breakfast, from the monitoring of pesticide residues to the nutritional labeling of products;

▪ during personal care, cosmetics such as soaps, toothpastes, and sunscreens undergo regulation that prevents hazardous substances from reaching the end consumer;

▪ at the pharmacy and the public health post, medicines and vaccines are certified for efficacy and safety, as is the network for blood, tissue, and organ donation within the Brazilian Unified Health System (Sistema Único de Saúde, SUS);

▪ in hospitals and clinics, equipment such as ventilators, cardiac monitors, and surgical supplies require prior approval from Brazil’s Health Regulatory Agency (Anvisa) before entering use;

▪ in household care, sanitizing products such as disinfectants and detergents undergo laboratory testing that confirms their effectiveness;

▪ at ports, airports, and borders, teams operate around the clock to prevent the entry of adulterated inputs and contain the spread of health hazards.

A network reaching national and international scale

To cover Brazil’s continental territory, the country relies on the National Health Surveillance System (Sistema Nacional de Vigilância Sanitária, SNVS), coordinated by Anvisa and composed of state, municipal, and federal district surveillance bodies, each with autonomy to issue operating licenses and conduct local inspections.

Internationally, Anvisa operates in alignment with the world’s leading regulatory agencies. This regulatory convergence allows rigorous technical standards to facilitate safe international trade and secure the Brazilian population’s access to cutting-edge technological innovations — whether in containing health emergencies, such as the Covid-19 pandemic, or in the rapid interdiction of adulterated products, such as cases of methanol contamination.

Economic and regulatory impact

Health surveillance extends well beyond enforcement, functioning as a relevant driver of the country’s economy and innovation. According to Brazil’s Institute of Geography and Statistics (Instituto Brasileiro de Geografia e Estatística, IBGE), products and services subject to regulation by Anvisa and the SNVS correspond to 22.7% of Brazil’s Gross Domestic Product (GDP) — a figure that underscores the centrality of this regulatory framework to the productive sector and to public health security.